The Lyme Disease Testing Market Growth is accelerating as technological innovations and increasing disease prevalence drive demand for more accurate, rapid, and accessible diagnostic solutions across global healthcare systems. Lyme Disease Testing Market Size was valued at 799.2 USD Million in 2024. The Lyme Disease Testing Market is expected to grow from 846.3 USD Million in 2025 to 1,500 USD Million by 2035. The Lyme Disease Testing Market CAGR (growth rate) is expected to be around 5.9% during the forecast period (2026 - 2035). The market growth is primarily driven by the increasing prevalence of Lyme disease globally, with the CDC reporting a nearly 300% increase in cases in the United States over the last two decades. The rise in tick populations owing to climate change and geographical expansion is enhancing the prevalence of Lyme disease, fueling the demand for comprehensive testing solutions. Technological advancements in diagnostic methods are significantly influencing the market, with innovations such as multiplex PCR assays and advanced serological tests enhancing the accuracy and speed of Lyme disease diagnostics. The growing awareness among healthcare professionals and the public, supported by educational campaigns from health organizations, is leading to more prompt testing and diagnosis.

The market expansion is being supported by significant technological advancements that are making Lyme disease testing more accurate, efficient, and accessible. Innovations in molecular diagnostics, such as PCR testing and serological tests, are notable advancements that can improve accuracy and speed in detecting the disease, thereby enhancing patient outcomes. The development of high-throughput serology panels for centralized laboratories is improving throughput and accuracy. The shift towards point-of-care testing methods is gaining momentum, enabling quicker results and ease of access, especially in remote areas where healthcare infrastructure may be limited. The growing emphasis on personalized medicine is encouraging the development of tailored therapies that require precise and timely diagnostics, further pushing the demand for effective testing methodologies. The integration of AI and machine learning into diagnostic platforms is enhancing test accuracy and turnaround time, significantly improving patient outcomes and satisfaction. These technological advancements are making Lyme disease testing more attractive to healthcare providers and patients, driving market expansion and creating new opportunities for innovation.

The growth of the Lyme disease testing market is being propelled by strategic collaborations and product launches among major players, with companies focusing on expanding their diagnostic portfolios and geographic reach. Key market players include Abbott Laboratories, Roche Diagnostics, Quest Diagnostics, ArminLabs, Hologic, Thermo Fisher Scientific, Bio-Rad Laboratories, Cepheid, and Biomérieux. Recent developments include Hologic's strategic collaboration with Infectious Disease Research Institute in November 2024 to co-develop next-generation Lyme disease diagnostics leveraging Hologic's molecular platforms. Roche Diagnostics announced in March 2025 the launch of a new multiplex Lyme disease PCR assay expanding its Lyme testing portfolio. Bio-Rad Laboratories announced in June 2025 a high-throughput Lyme disease serology panel for centralized laboratories, aimed at improving throughput and accuracy. The World Health Organization released guidelines emphasizing the need for standardized testing approaches to improve diagnostic accuracy, further driving market growth. The market has seen a rise in novel testing products, including polymerase chain reaction and serological tests, enhancing diagnostic capabilities.

Regionally, the Lyme disease testing market growth is being driven by varying dynamics across different geographies. North America is anticipated to dominate the market, spurred by rising incidences of Lyme disease and substantial investments in healthcare infrastructure to support diagnostic advancements. The region benefits from advanced healthcare infrastructure and a rising incidence of Lyme disease, leading to increased demand for efficient testing solutions. Europe follows closely, witnessing steady expansion driven by growing awareness of Lyme disease and increasing prevalence of tick-borne illnesses. The Asia-Pacific region is anticipated to experience rapid growth due to rising health concerns and improving healthcare infrastructure, with countries enhancing their healthcare infrastructure to improve disease management. South America and the Middle East and Africa are gradually emerging, with growing attention on Lyme disease diagnostics, thus contributing to the overall expansion of the market. As the market continues to evolve, organizations that can leverage these growth drivers and adapt to shifting healthcare needs will be well-positioned to capture significant market share in this steadily expanding industry.

Most Popular Market Research Reports:

Internet Of Thing Iot Data Management Market

Optical Communication And Networking Equipment Market

Global 3D Packaging Market

Stone Mining Quarrying Market One

Magnetic Market

Digital Identity Security Market

Iot Based Asset Tracking And Monitoring Market

Augmented Reality Technology Market

Fitness Technology Market